Medical oncology enhances comprehensive care options for patients with head and neck cancer

Medical oncology enhances comprehensive care options for patients with head and neck cancer

Jan. 16, 2025 Mayo Clinic is at the forefront of head and neck cancer treatment, offering…

Continue Reading
GE HealthCare announces CareIntellect for Oncology, harnessing AI to give clinicians an easy way to see the patient journey in a single view

GE HealthCare announces CareIntellect for Oncology, harnessing AI to give clinicians an easy way to see the patient journey in a single view

Application goes beyond data aggregation to help clinicians quickly see a longitudinal view of their patient’s…

Continue Reading
GE HealthCare Technologies Inc. (GEHC) Unveils AI Application for Oncology and Launches AI Innovation Lab to Drive Healthcare Advancements

GE HealthCare Technologies Inc. (GEHC) Unveils AI Application for Oncology and Launches AI Innovation Lab to Drive Healthcare Advancements

We recently compiled a list of the 15 AI News Investors Should Not Miss. In this article,…

Continue Reading
GE HealthCare Technologies Inc. (GEHC) Unveils AI Application for Oncology and Launches AI Innovation Lab to Drive Healthcare Advancements

GE HealthCare Technologies Inc. (GEHC) Unveils AI Application for Oncology and Launches AI Innovation Lab to Drive Healthcare Advancements

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking…

Continue Reading
Tampa General, UT Southwestern Evaluating GE HealthCare’s Oncology Application

Tampa General, UT Southwestern Evaluating GE HealthCare’s Oncology Application

GE HealthCare (Nasdaq: GEHC) says that Tampa General Hospital and UT Southwestern Medical Center are early…

Continue Reading
Takeda oncology pipeline remains robust despite shift in focus from CAR-T to allogeneic cell therapies, says GlobalData – Medical Devices News

Takeda oncology pipeline remains robust despite shift in focus from CAR-T to allogeneic cell therapies, says GlobalData – Medical Devices News

Takeda has decided to discontinue the development programs of its four oncology assets—Phase III asset modakafusp…

Continue Reading